Ingvas 20mg Tablet contains Rosuvastatin, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL particles from the bloodstream. Ingvas 20mg is prescribed to patients at high risk of cardiovascular events, including those with atherosclerotic cardiovascular disease, familial hypercholesterolemia, or multiple risk factors such as diabetes mellitus and hypertension. The dosage should be individualized based on patient response and lipid profile, with regular monitoring of liver function tests and creatine kinase recommended to detect potential adverse effects such as hepatotoxicity or myopathy. Common side effects may include headache, myalgia, abdominal pain, and nausea. Ingvas 20mg should be used cautiously in patients with pre-existing liver disease or renal impairment and is contraindicated during pregnancy and lactation. Adherence to lifestyle modifications, including diet and exercise, is essential to optimize therapeutic outcomes.